HEADER HORMONE RECEPTOR 13-APR-07 2PIN TITLE THYROID RECEPTOR BETA IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYROID HORMONE RECEPTOR BETA-1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (RESIDUES 209-461); COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: BL21; SOURCE 6 GENE: THRB, ERBA2, NR1A2, THR1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS THYROID RECEPTOR BETA, NUCLEAR RECEPTORS, INHIBITORS, PROTEIN-PROTEIN KEYWDS 2 INTERACTIONS, COREGULATOR BINDING, AF-2 POCKET, AROMATIC-BETA-AMINO KEYWDS 3 KETONES, STRUCTURE-BASED DRUG DESIGN, SURFACE INTERACTING DRUGS, KEYWDS 4 HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR E.ESTEBANEZ-PERPINA,N.JOURAVEL,J.D.BAXTER,L.R.GUY,P.WEBB, AUTHOR 2 R.J.FLETTERICK REVDAT 6 21-FEB-24 2PIN 1 REMARK REVDAT 5 20-OCT-21 2PIN 1 REMARK SEQADV REVDAT 4 18-OCT-17 2PIN 1 REMARK REVDAT 3 22-DEC-10 2PIN 1 REMARK REVDAT 2 24-FEB-09 2PIN 1 VERSN REVDAT 1 26-FEB-08 2PIN 0 JRNL AUTH E.ESTEBANEZ-PERPINA,L.A.ARNOLD,N.JOURAVEL,M.TOGASHI, JRNL AUTH 2 J.BLETHROW,E.MAR,P.NGUYEN,K.J.PHILLIPS,J.D.BAXTER,P.WEBB, JRNL AUTH 3 R.K.GUY,R.J.FLETTERICK JRNL TITL STRUCTURAL INSIGHT INTO THE MODE OF ACTION OF A DIRECT JRNL TITL 2 INHIBITOR OF COREGULATOR BINDING TO THE THYROID HORMONE JRNL TITL 3 RECEPTOR. JRNL REF MOL.ENDOCRINOL. V. 21 2919 2007 JRNL REFN ISSN 0888-8809 JRNL PMID 17823305 JRNL DOI 10.1210/ME.2007-0174 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 24674 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3927 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PIN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042414. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ELVES REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24674 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.43500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 209 REMARK 465 ILE A 255 REMARK 465 VAL A 256 REMARK 465 ASN A 257 REMARK 465 ALA A 258 REMARK 465 PRO A 259 REMARK 465 GLU A 260 REMARK 465 ASP A 461 REMARK 465 GLY B 209 REMARK 465 HIS B 210 REMARK 465 ASP B 461 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL B 256 CG1 CG2 REMARK 470 ASN B 257 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ALA A 234 C GLN A 235 N 0.156 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 234 CA - C - N ANGL. DEV. = 19.6 DEGREES REMARK 500 ALA A 234 O - C - N ANGL. DEV. = -20.6 DEGREES REMARK 500 GLN A 235 C - N - CA ANGL. DEV. = 27.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 235 -125.15 -159.52 REMARK 500 SER A 237 20.36 -163.51 REMARK 500 HIS A 238 109.44 68.62 REMARK 500 PRO A 247 131.97 -38.33 REMARK 500 ASN A 331 8.19 57.29 REMARK 500 GLU A 333 -19.92 -141.27 REMARK 500 LYS A 411 83.28 64.41 REMARK 500 HIS A 413 38.84 -90.36 REMARK 500 PHE A 459 52.03 -105.02 REMARK 500 SER B 237 76.04 -106.58 REMARK 500 HIS B 238 97.17 55.83 REMARK 500 ASN B 257 98.71 62.30 REMARK 500 ARG B 320 32.22 -98.18 REMARK 500 GLU B 333 -18.86 -152.39 REMARK 500 ASN B 364 66.99 39.23 REMARK 500 LYS B 411 78.88 61.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4HY A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4HY B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LEG A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LEG B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PIO RELATED DB: PDB REMARK 900 RELATED ID: 2PIP RELATED DB: PDB REMARK 900 RELATED ID: 2PIQ RELATED DB: PDB REMARK 900 RELATED ID: 2PIR RELATED DB: PDB REMARK 900 RELATED ID: 2PIT RELATED DB: PDB REMARK 900 RELATED ID: 2PIU RELATED DB: PDB REMARK 900 RELATED ID: 2PIV RELATED DB: PDB REMARK 900 RELATED ID: 2PIW RELATED DB: PDB REMARK 900 RELATED ID: 2PIX RELATED DB: PDB REMARK 900 RELATED ID: 2PKL RELATED DB: PDB DBREF 2PIN A 209 461 UNP P10828 THB1_HUMAN 209 461 DBREF 2PIN B 209 461 UNP P10828 THB1_HUMAN 209 461 SEQADV 2PIN ARG A 355 UNP P10828 ASP 355 ENGINEERED MUTATION SEQADV 2PIN ARG B 355 UNP P10828 ASP 355 ENGINEERED MUTATION SEQRES 1 A 253 GLY HIS LYS PRO GLU PRO THR ASP GLU GLU TRP GLU LEU SEQRES 2 A 253 ILE LYS THR VAL THR GLU ALA HIS VAL ALA THR ASN ALA SEQRES 3 A 253 GLN GLY SER HIS TRP LYS GLN LYS ARG LYS PHE LEU PRO SEQRES 4 A 253 GLU ASP ILE GLY GLN ALA PRO ILE VAL ASN ALA PRO GLU SEQRES 5 A 253 GLY GLY LYS VAL ASP LEU GLU ALA PHE SER HIS PHE THR SEQRES 6 A 253 LYS ILE ILE THR PRO ALA ILE THR ARG VAL VAL ASP PHE SEQRES 7 A 253 ALA LYS LYS LEU PRO MET PHE CYS GLU LEU PRO CYS GLU SEQRES 8 A 253 ASP GLN ILE ILE LEU LEU LYS GLY CYS CYS MET GLU ILE SEQRES 9 A 253 MET SER LEU ARG ALA ALA VAL ARG TYR ASP PRO GLU SER SEQRES 10 A 253 GLU THR LEU THR LEU ASN GLY GLU MET ALA VAL THR ARG SEQRES 11 A 253 GLY GLN LEU LYS ASN GLY GLY LEU GLY VAL VAL SER ASP SEQRES 12 A 253 ALA ILE PHE ARG LEU GLY MET SER LEU SER SER PHE ASN SEQRES 13 A 253 LEU ASP ASP THR GLU VAL ALA LEU LEU GLN ALA VAL LEU SEQRES 14 A 253 LEU MET SER SER ASP ARG PRO GLY LEU ALA CYS VAL GLU SEQRES 15 A 253 ARG ILE GLU LYS TYR GLN ASP SER PHE LEU LEU ALA PHE SEQRES 16 A 253 GLU HIS TYR ILE ASN TYR ARG LYS HIS HIS VAL THR HIS SEQRES 17 A 253 PHE TRP PRO LYS LEU LEU MET LYS VAL THR ASP LEU ARG SEQRES 18 A 253 MET ILE GLY ALA CYS HIS ALA SER ARG PHE LEU HIS MET SEQRES 19 A 253 LYS VAL GLU CYS PRO THR GLU LEU PHE PRO PRO LEU PHE SEQRES 20 A 253 LEU GLU VAL PHE GLU ASP SEQRES 1 B 253 GLY HIS LYS PRO GLU PRO THR ASP GLU GLU TRP GLU LEU SEQRES 2 B 253 ILE LYS THR VAL THR GLU ALA HIS VAL ALA THR ASN ALA SEQRES 3 B 253 GLN GLY SER HIS TRP LYS GLN LYS ARG LYS PHE LEU PRO SEQRES 4 B 253 GLU ASP ILE GLY GLN ALA PRO ILE VAL ASN ALA PRO GLU SEQRES 5 B 253 GLY GLY LYS VAL ASP LEU GLU ALA PHE SER HIS PHE THR SEQRES 6 B 253 LYS ILE ILE THR PRO ALA ILE THR ARG VAL VAL ASP PHE SEQRES 7 B 253 ALA LYS LYS LEU PRO MET PHE CYS GLU LEU PRO CYS GLU SEQRES 8 B 253 ASP GLN ILE ILE LEU LEU LYS GLY CYS CYS MET GLU ILE SEQRES 9 B 253 MET SER LEU ARG ALA ALA VAL ARG TYR ASP PRO GLU SER SEQRES 10 B 253 GLU THR LEU THR LEU ASN GLY GLU MET ALA VAL THR ARG SEQRES 11 B 253 GLY GLN LEU LYS ASN GLY GLY LEU GLY VAL VAL SER ASP SEQRES 12 B 253 ALA ILE PHE ARG LEU GLY MET SER LEU SER SER PHE ASN SEQRES 13 B 253 LEU ASP ASP THR GLU VAL ALA LEU LEU GLN ALA VAL LEU SEQRES 14 B 253 LEU MET SER SER ASP ARG PRO GLY LEU ALA CYS VAL GLU SEQRES 15 B 253 ARG ILE GLU LYS TYR GLN ASP SER PHE LEU LEU ALA PHE SEQRES 16 B 253 GLU HIS TYR ILE ASN TYR ARG LYS HIS HIS VAL THR HIS SEQRES 17 B 253 PHE TRP PRO LYS LEU LEU MET LYS VAL THR ASP LEU ARG SEQRES 18 B 253 MET ILE GLY ALA CYS HIS ALA SER ARG PHE LEU HIS MET SEQRES 19 B 253 LYS VAL GLU CYS PRO THR GLU LEU PHE PRO PRO LEU PHE SEQRES 20 B 253 LEU GLU VAL PHE GLU ASP HET 4HY A 500 21 HET LEG A 501 16 HET SO4 B 501 5 HET 4HY B 500 21 HET LEG B 502 16 HETNAM 4HY [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC HETNAM 2 4HY ACID HETNAM LEG 1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE HETNAM SO4 SULFATE ION FORMUL 3 4HY 2(C14 H9 I3 O4) FORMUL 4 LEG 2(C15 H20 O) FORMUL 5 SO4 O4 S 2- FORMUL 8 HOH *320(H2 O) HELIX 1 1 THR A 215 THR A 232 1 18 HELIX 2 2 ASP A 265 LYS A 274 1 10 HELIX 3 3 ILE A 275 LYS A 289 1 15 HELIX 4 4 LEU A 290 GLU A 295 1 6 HELIX 5 5 PRO A 297 VAL A 319 1 23 HELIX 6 6 THR A 337 GLY A 344 1 8 HELIX 7 7 VAL A 348 LEU A 360 1 13 HELIX 8 8 ASP A 366 MET A 379 1 14 HELIX 9 9 CYS A 388 LYS A 411 1 24 HELIX 10 10 HIS A 416 CYS A 446 1 31 HELIX 11 11 PRO A 447 PHE A 451 5 5 HELIX 12 12 PRO A 452 PHE A 459 1 8 HELIX 13 13 THR B 215 ALA B 231 1 17 HELIX 14 14 HIS B 238 ARG B 243 1 6 HELIX 15 15 ASP B 265 LYS B 274 1 10 HELIX 16 16 ILE B 275 LYS B 289 1 15 HELIX 17 17 LEU B 290 LEU B 296 1 7 HELIX 18 18 PRO B 297 VAL B 319 1 23 HELIX 19 19 ARG B 338 GLY B 344 1 7 HELIX 20 20 GLY B 347 LEU B 360 1 14 HELIX 21 21 SER B 361 ASN B 364 5 4 HELIX 22 22 ASP B 366 MET B 379 1 14 HELIX 23 23 CYS B 388 LYS B 411 1 24 HELIX 24 24 HIS B 416 CYS B 446 1 31 HELIX 25 25 PRO B 447 PHE B 451 5 5 HELIX 26 26 PRO B 452 VAL B 458 1 7 SHEET 1 A 4 LYS A 244 PHE A 245 0 SHEET 2 A 4 MET A 334 VAL A 336 1 O ALA A 335 N LYS A 244 SHEET 3 A 4 THR A 327 LEU A 330 -1 N LEU A 330 O MET A 334 SHEET 4 A 4 TYR A 321 ASP A 322 -1 N ASP A 322 O THR A 327 SHEET 1 B 4 LYS B 244 PHE B 245 0 SHEET 2 B 4 MET B 334 THR B 337 1 O ALA B 335 N LYS B 244 SHEET 3 B 4 THR B 327 LEU B 330 -1 N LEU B 330 O MET B 334 SHEET 4 B 4 TYR B 321 ASP B 322 -1 N ASP B 322 O THR B 327 SITE 1 AC1 7 ASN A 364 HIS A 412 HIS A 413 ASN B 364 SITE 2 AC1 7 HIS B 412 HIS B 413 HOH B 519 SITE 1 AC2 10 PHE A 272 MET A 313 ALA A 317 ARG A 320 SITE 2 AC2 10 LEU A 330 ASN A 331 ILE A 353 HIS A 435 SITE 3 AC2 10 MET A 442 HOH A 541 SITE 1 AC3 11 PHE B 272 MET B 313 ALA B 317 ARG B 320 SITE 2 AC3 11 LEU B 330 ASN B 331 GLY B 344 LEU B 346 SITE 3 AC3 11 ILE B 353 HIS B 435 PHE B 455 SITE 1 AC4 3 THR A 281 LYS A 306 LEU A 454 SITE 1 AC5 2 LYS B 306 LEU B 454 CRYST1 55.130 92.870 58.350 90.00 109.65 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018140 0.000000 0.006480 0.00000 SCALE2 0.000000 0.010770 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018200 0.00000